April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Combined Reduced-Fluence Photodynamic Therapy and Intravitreal Anti-VEGF Antibody Injection for the Treatment of Myopic Choroidal Neovascularization
Author Affiliations & Notes
  • Hyun Woong Kim
    Ophthalmology, Busanpaik Hospital, Inje University College of Medicine, Busan, Republic of Korea
  • Il Han Yun
    Ophthalmology, Busanpaik Hospital, Inje University College of Medicine, Busan, Republic of Korea
  • Footnotes
    Commercial Relationships  Hyun Woong Kim, None; Il Han Yun, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2720. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hyun Woong Kim, Il Han Yun; Combined Reduced-Fluence Photodynamic Therapy and Intravitreal Anti-VEGF Antibody Injection for the Treatment of Myopic Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2720.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the effect of combined reduced-fluence photodynamic therapy and intravitreal anti-VEGF antibody injection for the treatment of myopic choroidal neovascularization.

Methods: : 13 eyes of 13 patients who underwent combined reduced-fluence photodynamic therapy and intravitreal anti-VEGF antibody injection for the myopic CNV, and were followed up more than 12 months. Their medical records were retrospectively investigated and the best corrected visual acuity, central macular thickness, and leak in fluorescein angiography were compared.

Results: : The mean best corrected visual acuity(logMAR) was 1.03, 0.88, 0.76, 0.71, 0.73 at baseline, 1, 3, 6, 12 months(P<0.05). The mean central macular thickness was 292.46µm, 185.46µm at baseline, 3 months. In fluorescein angiography at 3 months after treatment, resolution was observed in 5 eyes, and reduction in 8 eyes.

Conclusions: : Combined reduced-fluence photodynamic therapy and intravitreal anti-VEGF antibody injection for the myopic CNV appeared to be effective in regression of lesion and improvement of visual acuity.

Keywords: choroid: neovascularization • myopia • vascular endothelial growth factor 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×